| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 土克甾酮; Turkesterone | CFN90217 | 41451-87-0 | C27H44O8 = 496.64 | 5mg | QQ客服：2056216494 |
| 远志山酮III; Polygalaxanthone III | CFN90208 | 162857-78-5 | C25H28O15 = 568.39 | 20mg | QQ客服：215959384 |
| 大蒜素; Allicin | CFN90201 | 539-86-6 | C6H10S2O = 162.27 | 20mg | QQ客服：1413575084 |
| 七叶胆苷XVI; Gypenoside XVII | CFN90193 | 80321-69-3 | C48H82O18 = 947.16 | 20mg | QQ客服：3257982914 |
| 异甘草素； 4,2',4'-三羟基查耳酮; Isoliquiritigenin | CFN97542 | 961-29-5 | C15H12O4 = 256.3 | 20mg | QQ客服：1457312923 |
| 15-羟基-7-氧代去氢松香酸; 15-Hydroxy-7-oxodehydroabietic acid | CFN97533 | 95416-25-4 | C20H26O4 = 330.4 | 5mg | QQ客服：2159513211 |
| 异秦皮啶; Isofraxidin | CFN90181 | 486-21-5 | C11H10O5 = 222.19 | 20mg | QQ客服：2056216494 |
| (-)-鹰爪豆碱; (-)-Sparteine | CFN90180 | 24915-04-6 | C15H26N2 = 234.38 | 10mg | QQ客服：2056216494 |
| 茶黄素 3-没食子酸酯; Theaflavin-3-gallate | CFN90170 | 30462-34-1 | C36H28O16 = 716.60 | 20mg | QQ客服：2159513211 |
| β,β-二甲基丙烯酰紫草素; Dimethylacrylshikonin | CFN90164 | 24502-79-2 | C21H22O6 = 370.39 | 20mg | QQ客服：215959384 |
| 二氢异丹参酮I; Dihydroisotanshinone I | CFN90162 | 20958-18-3 | C18H14O3 = 278.30 | 10mg | QQ客服：215959384 |
| 育亨宾; Yohimbine | CFN90147 | 146-48-5 | C21H26N2O3 = 354.44 | 20mg | QQ客服：3257982914 |
| 二氢丹参酮I; Dihydrotanshinone I | CFN97435 | 87205-99-0 | C18H14O3 = 278.3 | 20mg | QQ客服：1457312923 |
| 3,23-二氧代-9,19-环羊毛甾-24-烯-26-酸 ; 3,23-Dioxo-9,19-cyclolanost-24-en-26-oic acid | CFN97432 | 870456-88-5 | C30H44O4 = 468.7 | 5mg | QQ客服：2056216494 |
| 灵芝酸SZ; Ganoderic acid SZ | CFN97426 | 865543-37-9 | C30H44O3 = 452.7 | 5mg | QQ客服：1457312923 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)